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Research highlights 
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√ Tween 20 as edge activator in DOPC:DMPC liposome is six times more deformable than 
conventional liposome; 
√ Substantial skin permeation of the photossensitizer, ZnPc encapsulated in UDLs; 
√ UDL ZnPc/RuNO is toxic for melanoma cells when irradiated at 675 nm but not in the absence of 
light. 
 
 
 
 
 
 
 
Abstract 
Ultradeformable liposomes (UDLs) as a drug delivery system (DDS), prepared from the 
unsaturated phospholipid, dioleylphosphocholine (DOPC), and containing the non-ionic 
surfactant Tween 20 as edge activator, have been explored as topical vehicles for zinc 
phthalocyanine (ZnPc) and the nitrosyl ruthenium complex [Ru(NH.NHq)(tpy)NO]3+ (RuNO) 
as a photosensitizers for co-generation of 1O2 and NO as reactive species, respectively. 
However, in order to ensure that ZnPc was present in the UDLs in its monomeric form - 
essential for maximal ZnPc photophysical properties - it was necessary to replace 40 wt% of 
the DOPC with the saturated phospholipid, dimyristoylphosphocholine (DMPC). The resultant 
ZnPc and complex [Ru(NH.NHq)(tpy)NO]3+ containing UDLs were stable for at least a month 
when stored at 4 oC, six times more elastic/deformable than conventional liposome (c-Ls), i.e. 
liposome prepared using the same weight ratio of lipids but in the absence of Tween 20, and 
to significantly enhance the in vitro permeation of ZnPc across fresh pig ear skin. The UDLs 
DDS incorporating ZnPc and [Ru(NH.NHq)(tpy)NO]3+ were toxic (by the MTT assay) towards 
B16-F10 melanoma cells when irradiated with visible light at 670 nm, the maximum 
absorption of ZnPc, and at a dose of 3.18 J/cm2, but not when applied in the absence of light 
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as expected. Based on these results it is proposed that the novel topical UDLs formulation 
developed is a suitable delivery vehicle for photodynamic therapy. 
 
Keywords: ultradeformable liposome; nitrosyl ruthenium complex; zinc phthalocyanine; 
photodynamic therapy 
 
 
 
 
 
 
1.Introduction 
In a solid tumor, the high rate of cell proliferation and abnormal vasculature network 
result in a highly heterogeneous microenvironment which means that some regions of the 
tumor are well perfused while others are starved of oxygen - a phenomenon called as hypoxia 
[1-2]. Hypoxia is known to be the most important cause of clinical radioresistance. The low 
levels of oxygenation in a tumor is responsible for many side effect problems compromising 
the success of photodynamic therapy (PDT), which requires the presence of oxygen for the 
effective generation of reactive oxygen species (ROS) during the process, that will induce a 
cascade of events (apoptosis and necrosis), leading to the cell death. 
In order to overcome the poor oxygenation levels in tumors, it has been proposed that 
a combination between the zinc phthalocyanine (ZnPc), known to produce ROS upon the 
application of visible light, and a nitric oxide (NO) donating agent, such as a nitrosyl ruthenium 
complex [3-7], should be used to significantly improve the likelihood of PDT being successful 
[8-9]. The advantage of including an NO donating agent is because it (NO) is an efficient 
radiosensitizer under hypoxic conditions, mimicking the effects of oxygen radiation-induced 
DNA damage [2, 10-11]. Motived for the use nitrosyl ruthenium complexes as NO agent donor 
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by light irradiation on the therapeutic window (600-800 nm), proposed a combination of both, 
an ROS producing agent like zinc phthalocyanine compound, and a NO-donating compound 
as ruthenium nitrosyl complex, acting synergistically in death of the neoplastic cells [8,12-13].  
PDT is a potentially exciting, non-invasive treatment for dermatological conditions such 
as melanoma, if the main barrier namely the stratum corneum (SC), which limits the 
permeability of many therapeutically active compounds across the skin, can be overcome to 
the successful delivery of compounds into the skin [14-15]. A potential means to overcome 
the stratum corneum (SC) is to deliver the PDT agents in ultradeformable liposomes (UDLs) 
[16-17]. UDLs are generally prepared from a mixture of conventional (vesicle-forming) 
phospholipids (generally in their fluid phase) combined with a molecule known as an edge 
activator, typically a surfactant (e.g. a bile salt or a Span) or a co-solvent (e.g., ethanol). The 
presence of an edge activator allows the UDLs to undergo strong, spontaneous fluctuations in 
structure [16,18-22], so that UDLs can deform sufficiently to penetrate pores 1/5th of their 
own size, and as a result, traverse the water-filled gaps between the lipid layers separating 
the skin cells. The high flexibility is due to the fact that elastic energy of the UDLs is of the 
order of the ambient thermal energy (kT), and is approximately 20 times lower than that of 
conventional liposomes (c-Ls) i.e. liposomes with one or more bilayers of phospholipids 
prepared in the absence of an edge activator [16, 23-24]. The transport of UDLs into the skin 
is greatly enhanced if the UDLs are not occluded upon application to the surface of the skin, 
so that the transepidermal hydration gradient which results as a consequence can drive the 
passage of the UDLs into the skin. UDLs are currently being investigated as carriers for the 
transdermal delivery of a range of drug molecules including non-steroidal anti-inflammatory 
drugs [25] and steroids [26]. 
The hypothesis in the present study, is the transdermal application of two compounds 
formulated in the same DDS, the zinc phthalocyanine, which produces reactive oxygen 
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species (ROS) by Type I and Type II mechanism [27], and a nitrosyl ruthenium complex 
which generates reactive nitric oxide species (RNOs). Both compounds packaged in a UDLs 
formulation should provide a very efficient means of destroying skin melanomas after 
irradiation of the skin with visible light of an appropriate wavelength.  
The main objective of the present research was, therefore, to develop and 
characterize, from a physico-chemical and cellular viewpoint, the potential of a UDLs system 
loaded with zinc phthalocyanine, ZnPc and the nitrosyl ruthenium complex, 
[Ru(NH.NHq)(tpy)NO]3+, (Figure 1) for use in PDT from treatment of skin melanomas. 
 
INSERT FIGURE 1A 
 
INSERT FIGURE 1B 
 
As previous studies [28] in our group, have shown that UDLs can be successfully 
prepared from fluid-phase phospholipids such as DOPC in combination with a non-ionic 
surfactant such as the pharmaceutically acceptable Tween 20 (Figure 2), it was decided in 
the present study to prepare UDLs from DOPC in combination with Tween 20 as vehicles for 
ZnPc and the nitrosyl ruthenium complex, [Ru(NH.NHq)(tpy)NO]3+ intended for use in PDT. 
 
INSERT FIGURE 2 
 
2. Experimental 
 
2.1. Chemical and Reagents  
Zinc phthalocyanine (ZnPc) was obtained from Aldrich (St. Louis, USA). The complex 
[Ru(NH.NHq)(tpy)NO](PF6)3 (RuNO) was synthesized by a procedure similar to that described 
by de Lima and co-workers [7]. In brief, the precursor complex [RuCl(NH.NHq)(tpy)]Cl was 
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dissolved in water with sodium nitrite (NaNO2) and refluxed under an atmosphere of argon for 
1 h. After this period, hexafluorphosphate acid (HPF6) was added to the solution with stirring 
and the resulting brown precipitate, namely the complex [Ru(NH.NHq)(tpy)NO](PF6)3, was 
isolated by filtration, washed with diethyl ether, and stored in the dark under vacuum until use. 
The complex [Ru(NH.NHq)(tpy)NO](PF6)3 (RuNO) was crystallized immediately prior to use. 
Dimyristoyl- and dioleoyl-phosphatidylcholine (DMPC and DOPC, respectively), purity >99%, 
were purchased from LIPOID (Germany) and Avanti (USA), respectively. Tween 20 
(polyoxyethylene (20) sorbitan monolaurate) was acquired from Fluka (UK). Chloroform and 
ethanol (analytical grade) were supplied by Merck (UK). All chemicals were the highest grade 
available and used without further purification. Ultrapure water (resistivity equal 18.0 M.cm) 
(Option 3-Maxima HPLC Ultra Pure Water, ELGA, UK) was used throughout the study and 
was filtered through a 200 nm polycarbonate filter (Millipore, UK) prior to use, in order to 
minimize interference from any extraneous particulate matter. 
 
2.2. Spectroscopic measurements 
Absorption measurements were performed over a wavelength range of 300 – 800 nm 
using a double beam Perkin-Elmer Lambda 20 spectrophotometer (Perkin-Elmer, US). The 
concentration of the ZnPc and RuNO were determined spectrophotometrically at the λmax 
using ε670 = 2.04 × 105 L−1 mol cm-1 for ZnPc in an organic solvent, namely DMF/DMSO (ZnPc 
is a hydrophobic compound) [8], and ε355 = 9550 L−1 mol cm-1 for RuNO in aqueous solution 
[7].  
 
2.3. Preparation of the ultradeformable liposomes  
Ultradeformable liposomes (UDLs) composed of a 60:40 wt% ratio of 
dioleoylphosphatidylcholine (DOPC) and dimyristoylphosphatidylcholine (DMPC), with and 
without Tween 20, as well as liposomes composed solely of DOPC, were prepared according 
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to the injection method [29]. Regardless of type, all liposomes were prepared by the injection 
of 360 µL of an ethanolic solution, containing sufficient lipid/lipid mixture for a final 
concentration of 2 mg/mL, at a flow rate of 1 µL/s, into 5 mL of a stirred solution of phosphate 
buffer (pH 7.4) at 40 oC. Where appropriate, the ethanolic solution also contained enough 
Tween 20 for a final concentration of 5 mmol L-1, equivalent to a concentration of 6 mg/mL. 
When preparing the ZnPc-containing liposomes, 50 µL of ZnPc in a 1:1 (vol%) DMF/DMSO 
mixture was typically added to ethanol (360 µL), so that a concentration of 5 µmol L-1 ZnPc 
would be achieved in the final liposome suspension, although other concentrations of ZnPc 
were also examined in the study. For the RuNO-containing liposomes, RuNO complex was 
incorporated by dissolving the required amount in aqueous phase to result in a concentration 
of 50 µmol L-1 in the liposomal suspension [8]. For associated ZnPc/RuNO UDLs formulation, 
firstly, the ZnPC-containing liposome were prepared like above, and after the RuNO complex 
was incorporated by dissolving the required amount in liposome suspension.  
 
2.4. Determination Entrapping Efficiency (%EE) 
The percentage of RuNO complex encapsulated in the liposomes was determined by 
measuring the amount of free/entrapped complex in the supernatant after ultracentrifugation 
of the suspension [30]. In brief, immediately after preparation the liposomal suspensions were 
stored at 4 oC overnight before ultracentrifugation at 40,000 rpm for 40 min using a L8-70M 
Ultracentrifuge (Beckman, UK). Free RuNO was then assayed by determining the UV 
spectrum of the supernatant using wavelength at 355 nm (ε355 nm = 9550 L-1 mol cm-1), when 
measured over the wavelength range of 300 – 800 nm using a Perkin-Elmer Lambda 20 
spectrophotometer (Perkin-Elmer, US). The percentage RuNO entrapment was calculated 
from the equation 1: 
                                          (1) 
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where %EE is the entrapment efficiency, Qt is the amount of RuNO that was added during 
UDLs preparation, and Qs is the amount of RuNO detected only in the supernatant after 
ultracentrifugation. The %EE data were obtained from three different liposomal preparations. 
 
2.5. Determination of the solubility of the nitrosyl ruthenium complex 
The aqueous solubility of RuNO was determined using a slight modification of the 
procedure of Al-Maaieh and Flanagan [31]. In brief, excess RuNO was added to 1 mL of 
water contained in a 1.5 mL centrifuge tube, which was sonicated at ambient temperature (22 
oC) for 1 minute and centrifuged for 1 h at 10,000 rpm to sediment excess RuNO (Microfuge, 
UK). The RuNO-saturated supernatant was then removed, filtered through a 50 nm cellulose 
acetate membrane (Sartorius, Germany) under an external pressure of 14.5 psi (or 1 bar), 
diluted in water and at the λmax of the absorbance of the resulting solution measured over the 
wavelength range of 300-800 nm using a double beam Perkin-Elmer Lambda 20 
spectrophotometer (Perkin-Elmer, US). 
 
2.6. Dynamic light scattering 
The apparent hydrodynamic size of the various species present in the mixed 
lipid:Tween 20 systems were measured using dynamic light scattering (DLS). The DLS 
measurements were performed using an ALV-5000 system comprising a compact goniometer 
system and a multi- real–time digital correlator (AL-Laser Vertriebsgesellschaft m.b.H, 
Langen, Germany). The instrumentation was equipped with a 22 mW He-Ne laser source, 
operating at a wavelength of 632.8 nm. The duration of a single-size measurement was 
typically 30 s, averaged over a minimum number of three runs, until a statistically significant 
result was obtained. The apparent hydrodynamic size of the particulate species in the sample, 
and the total intensity of the scattered light were measured at a temperature of 25 oC, and at 
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angles ranging from 30 to 150o. However, unless otherwise stated, the apparent 
hydrodynamic size obtained at 90o is quoted. Samples for examination by DLS were placed in 
cylindrical light scattering cuvette (Pyrex disposable culture tubes, Corning Inc., Corning, NY, 
USA). In order to minimize dust contamination, all operations involved in the preparation of 
the samples for light scattering were performed in a laminar airflow cabinet. In the current 
study, the intensity-weight distribution of the apparent hydrodynamic radius was determined 
from the autocorrelation function using a Laplace inversion routine, which employs the 
constrained regularization method (CONTIN program). 
2.7. Apparent hydrodynamic size and zeta potential 
The apparent hydrodynamic size, polydispersity index (PDI), and zeta potential of c-Ls 
and UDLs were determined by dynamic light scattering with Zetasizer Nano-ZS equipment 
(Malvern Instruments, Malvern, UK). All measurement were performed at room temperature 
(25 oC), at least two independent fresh samples were taken. 
 
2.8. Stability of liposome formulations 
The apparent hydrodynamic size-stability of the liposome formulations during storage 
was determined after 1 month storage at 4 oC in a darkened room and undiluted.  
 
2.9. Quantitative determination of phospholipids 
The concentration of phospholipid in a liposomal suspension before, and after its 
extrusion through a polycarbonate membrane (pore size either 50 or 100 nm, Millipore, UK) in 
a cycle of 3 times at ambient temperature (22 oC) was determined using an inorganic 
phosphate assay [32]. In brief, 0.4 mL of the liposome suspension, before and after its 
passage through the polycarbonate membrane was freeze-dried for 24 h and reconstituted in 
1 mL of chloroform. To this lipidic chloroform solution, 1 mL of a 0.1 mol L-1 ammonium 
ferrothiocyanate solution (prepared using 270.3 g/L ferric chloride hexahydrate and 30.4 g/L 
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ammonium thiocyanate in double-distilled water) was added, and the resulting mixture 
vigorously vortexed for 15 s followed by 10 min centrifugation at 2,000 rpm, in order to 
separate the aqueous and organic (chloroform) layers. 
0.3 mL of the organic layer was diluted with 3 mL of chloroform, and the absorbance of 
the resulting chloroform solution measured over the wavelength range 300-800 nm, λmax at 
485 nm, after correction for the chloroform solvent, using a double beam Perkin-Elmer 
Lambda 20 spectrophotometer (Perkin-Elmer, US). The concentration of lipid in the 
chloroform solution was determined by comparison with a standard curve constructed from 
samples, prepared in the same way, but containing known amounts of phospholipid. 
 
2.10. Deformability tests 
In order to evaluate the deformability of the UDLs and conventional liposomes (c-Ls), 
their permeation at ambient temperature (22 oC), under pressure, across an artificial 
membrane of known pore size was determined. 1 mL of liposome suspension was passed, 
under external pressure of 14.5 psi (or 1 bar), through either a 100 or 50 nm polycarbonate 
membrane filter (Millipore, UK) held in a stainless steel pressure filter holder (Satorius, 
Germany). The time taken for 1 mL of an UDLs suspension to pass through 100 and 50 nm 
pore size filters was 20 and 30 s, respectively. The apparent hydrodynamic size of liposomes 
before and after passage across the filters was measured as described below. 
 
2.11. Calculation of the deformability index 
The deformability index [14] was defined from the equation 2: 
                                   (2) 
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where V is the ratio of the volume of liposomal suspension passed, m is the ratio of the 
phospholipid crossing the membrane (calculated by dividing the concentration of phospholipid 
in the filtrate by that in the initial liposome suspension), and (rv/rp)2 is a factor related to the 
liposome size where rv is the liposome size after filtration and rp is the radius of the membrane 
pores. 
 
 
 
2.12. Degree of retention of entrapped solute after extrusion 
The degree of retention (DR) of ZnPc and RuNO after passage of UDLs containing 
these solutes through polycarbonate filters of 100 and 50 nm pore size, at ambient 
temperature (22 oC), was determined using UV/vis. analysis of the filtrate using a Perkin-
Elmer Lambda 20 spectrophotometer (Perkin-Elmer, US). The absorbance was corrected for 
background using matched quartz cuvette and for light scattering due to the presence of 
liposomes using the method of Arvinte and co-workers [33]. The DR was calculated from the 
equation 3: 
                                     (3) 
where Abs100 nm is the absorbance of the liposome suspension after passage through filters of 
100 nm pore size, and Abs0 is the absorbance of the liposome suspension before passage 
through the nanoporous polycarbonate filters. The DR were obtained from the measurement 
of two different liposome preparations (n = 2). 
 
2.13. Permeation across fresh pig ear skin 
The fresh pig ear skin was used as a model of human skin in the present study. To this 
end, the fresh pig ear skin was isolated and treated as previously described [34-35]. The 
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thickness of the pig ear skin was normalized at 75 mm using a dermatome (Robins 
Instruments, USA). After isolation of the skin, it was either used immediately or frozen under 
storing at – 20 oC for a maximum of 30 days prior to use. 
The in vitro skin profile release and retention studies were performed using the fresh 
pig ear skin fixed in Franz diffusion cells of surface area of 1.77 cm2. The receptor 
compartment was 7 mL of phosphate buffered saline, pH 7.4, containing 20% (v/v) ethanol to 
aid solubility of the hydrophobic ZnPc [36], and was maintained at 32 - 37.0 oC [23] by means 
of an external circulating water bath. 400 µL of a UDLs formulation containing ZnPc (without 
RuNO) was applied (under non-occlusive conditions) to the exterior surface of the skin and 
the permeation of ZnPc across the skin measured over 7 h by assaying the receptor fluid its 
presence of ZnPc.  
The Franz cells were dismantled 12 h after the application of the liposomal 
formulations and the fresh pig ear skin removed for determination of the amount of ZnPc 
present. Firstly, the skin was carefully rinsed with distilled water to remove residual 
formulation on the skin and dried with filter paper. After the skin samples had been attached 
and fixed on a smooth surface, the stratum corneum (SC) was removed using adhesive tape, 
and stripping 15 times (Scotch 3 M, Brazil). The 15 tape-strips were placed in 5 mL of DMSO 
in a glass tube, stored overnight, and then stirred for 1 min before the DMSO was filtered 
using filter paper. The remaining skin (viable epidermis and dermis) were cut into small pieces 
used for the extraction process. In the extraction process, 5 mL of DMSO were added to 
epidermis/dermis (ED) pieces. These samples were stirred for 20 min in ultrasonic sonicated 
bath (Brasonic 1800 model, 40 Hz). After filtration through a 0.45 µm polycarbonate 
membrane, the supernatant containing amount of ZnPc in the epidermis and dermis were 
determined using fluorescence spectroscopy. Fluorescence measurements were performed 
using a Fluorolog–Spex spectrofluorometer (Ivon–Jobin SPEX, USA), using an excitation 
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wavelength (λex) of 610 nm and emission wavelength (λem) of 680 nm; slits were adjusted to 5 
and 5, respectively. A calibration curve for ZnPc in 1:1 (vol%) phosphate buffered saline pH 
7.4 containing 20% (v/v) ethanol/acetonitrile was prepared in the concentration range of 
0.035-0.22 µmol L-1. 
 
 
 
2.14. Cell viability 
The methodology employed to evaluate the toxicity of the UDLs formulations was 
based on the classical MTT assay [38], in which the 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl 
tetrazolium bromide after mitochondrial reduction produce the formazan colorimetric 
compounds used as an indicator of cell viability. B16-F10, murine melanoma cells, maintained 
in RPMI-1640 medium (Gibco, Brazil) complemented with 10% fetal bovine serum (Gibco, 
Brazil) and 1% penicillin streptomycin (Gibco, Brazil), were cultured in 60 cm2 flasks at 37 oC 
in humidified air containing 5% CO2. The melanoma cells were used when in the logarithmic 
phase of their growth.  
B16-F10 cells (plated at 5 x 104 cells/well in 96-well plates) were incubated with 100 µL 
either empty UDLs or UDLs formulations containing either RuNO (5 µmol L-1), ZnPc (0.5 µmol 
L-1) or ZnPc/RuNO (0.5 µmol L-1 and 5 µmol L-1) at 37.0 oC. The aqueous micellar solutions of 
Tween 20 in different concentration were available. After 3 h incubation, the cells were 
washed with 200 µL Hank´s buffer (Gibco, Brazil) to remove the UDLs formulations and 200 
µL of RPMI-1640 medium added to each well and the cells incubated at 37oC for a further 24 
h after which time the cells were washed again with a further 200 µL of Hank´s buffer and 100 
µL of a 0.5 mg/mL MTT solution added to each well. After 4 h incubation at 37oC, the MTT 
solution was removed and any insoluble formazan crystals dissolved in isopropanol. The 
absorbance of the isopropanol solution was measured at 570 nm and 690 nm in a microplate 
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reader (ELISA, Corning, USA). The percentage cell viability was calculated with respect to 
control cells treated in the same way but in the absence of a UDLs formulation. All 
experiments were performed in triplicate with an average of 12 wells being used for each test 
condition. The statistical significance (P-value) of the results was determined by Student’s t-
test, using Igor-Pro for statistical analysis. 
 
2.15. Phototoxicity assay 
B16-F10 cells were incubated for 3 h under identical conditions to those used 
described above in the cell viability assay. The B16-F10 cells were incubated with 100 µL of a 
UDLs formulation containing ZnPC (0.5 µmol L-1), and other ZnPc/RuNO (0.5 µmol L-1 and 5 
µmol L-1). After the 3 h incubation the cells were irradiated for 5 s with visible laser. The PDT 
protocol used: the cells were irradiated for 5 s with light of a wavelength of 675 nm (Eagle 
Laser, Quantum Tech, São Carlos, Brazil), potency of 0.4 W, energy of 10 J, and dose of 3.18 
J/cm2. Immediately after exposure to the light, the cells were washed Hank´s buffer and 
incubated with 200 µL RPMI 1640 for 24 h at 37oC and cell viability determined after this 
period using the MTT assay as described above. Control cells were incubated with RPMI 
1640 medium for 3h and irradiated using the same conditions. All experiments were 
performed in triplicate with an average of 12 wells use for each test condition. The statistical 
significance (P-value) of the results was determined by Student’s t- test and Prism Biostatical 
software. 
 
3. Results and Discussion 
 
3.1. Selection of the composition of the ultradeformable liposome 
Using the extrusion method, our group has previously demonstrated that liposomes 
prepared from DOPC in combination with Tween 20 exhibited a high degree of deformability 
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at room temperature (22 oC) [28]. In contrast, DOPC vesicles prepared in the absence of 
Tween 20 were far less flexible despite the fact that DOPC exhibits a phase transition of – 
15.5 oC [39], illustrating the need for the presence of an edge activator when preparing UDLs. 
As a consequence of these results our initial formulation studies expose the potential of 
Tween 20-containing DOPC liposomes as a feasible DDS for the topical delivery to the 
combination of photoactive compounds, ZnPc and RuNO.  
Based on the physico-chemical properties of each of the drugs, it was expected that 
ZnPc would be one of the best candidate to be incorporated into the lipid bilayer of the 
liposome [41]. ZnPc exhibit hydrophobic nature confirmed by n-octanol/water partition 
coefficient (Log P= 2), which ZnPc has a n-octanol/water ratio equal 100 [40], and complete 
absence of water solubility. While the RuNO compound, show high aqueous solubility 
(determined in the present study as 1.73 g/L) and lower trapping efficiency (%EE = 19.0  3.2 
(n=3)). The RuNO complex can be dissolved in the aqueous space present in the liposome, 
i.e. in the core or the aqueous layers between bilayers in the case of any multilamellar 
vesicles formed [8].  
DOPC liposome was prepared by the ethanolic injection method, where were analyzed 
the ability of stabilize ZnPc and RuNO in monomeric form of these molecules in liposomal 
vesicle using UV-visible spectroscopy. The spectroscopy studies were demonstrated that 
DOPC liposomes were unsuitable for entrapping ZnPc due indications of aggregations.  
Figure 3 shows the absorption spectrum (solid black line) of an organic solution of 
DMSO/DMF containing 5 µmol L-1 of the photosensitizer, ZnPc. The ZnPc spectrum displays 
an absorption maximum at 670 nm, i.e. a Q-band arising from a π-π* transition, indicating that 
at this concentration, ZnPc was present in the DMSO/DMF solution in its monomeric form [42-
44].  
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The spectral profile of a freshly DOPC liposomal preparation containing ZnPc (5 µmol 
L-1) and RuNO (50 µmol L-1) were evaluated for fresh preparation and after 48 hours (Figure 
3). Significantly for this part of the study, the UV-vis. spectrum of freshly prepared liposome in 
the presence of ZnPc and RuNO (Figure 3, dashed line) exhibits the Q-band at 670 nm, 
suggesting that, at least initially, the ZnPc is present in the DOPC liposomes in its monomeric 
form, c.f. the UV-vis. spectrum obtained for ZnPc in DMSO:DMF (Figure 3, solid black line). In 
addition, the UV-vis. spectrum of the ZnPc and RuNO containing-liposomes displays a 
shoulder at 355 nm due to the presence of RuNO and is assignable to a metal-ligand charge 
transfer arising from the dπ(RuII)→π*(NO) transition [7-8]. 
 
INSERT FIGURE 3 
 
As can be seen from Figure 3 the UV-vis. spectra of the DOPC liposomes containing 
both ZnPc and RuNO changes over 48 h when stored at 25.0 ± 2.0 oC, suggesting that there 
is a change occurring within the formulation. In particular, there was a decrease in the 
intensity of the Q-bands at 606, 641, and 672 nm, an effect which is characteristic of the 
aggregation of ZnPc in the system under study [44]. Interestingly a similar aggregation over 
time has also been observed for other photosensitizer molecules encapsulated into liposomes 
containing DOPC [44-45]. These results suggest that DOPC liposomes are unsuitable 
vehicles for the delivery of ZnPc, at least at the desired ZnPc concentration of 5 µmol L-1. 
Aggregated form of photosensitizes are generally much less effective in PDT compared with 
their monomeric counterparts due to poor photosensitizing properties [44-45]. For example, 
Zimcik and co-workers [44] found that PC-dimers (phthalocyanines in dimeric form) exhibit a 
reduced cellular uptake, increased release from plasma, and a high level of accumulation of 
the photosensitizer in the liver, due to its fast release. Although it was not explored in the 
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present study, it may be possible to prepare DOPC liposomes containing ZnPc in the 
monomeric form by adding a lower amount of ZnPc. 
Phthalocyanines as photosensitizer have been reported to be more soluble in their 
monomeric form in liposomes prepared from chain-saturated phospholipids, such as DMPC 
and DPPC, where solubilities of 7mg ~ ZnPc/g lipid have been reported [24,45]. Liposome 
prepared from chain-unsaturated phospholipids, such as soybean and DOPC, present 
phthalocyanines solubility of 1.7 mg/g lipid and 1.8 mg/g lipid, respectively [16,44]. On the 
basis of these results, it was decided to explore the possibility of encapsulating 5 µmol L-1 of 
ZnPc in the monomeric form in liposomes prepared from a mixture of unsaturated and 
saturated lipids. DMPC was selected as the saturated phospholipid for study because it 
readily allows the formation of vesicles, and possesses a relatively low phase-transition of ~ 
24.0 oC [46] (c.f. to – 15.5 oC for DOPC [39]). As a consequence, it should be possible to 
retain the deformability of the liposomal formulation, while, at the same time, increasing the 
amount of monomeric ZnPc incorporated. A mixture of 60:40 wt% DOPC:DMPC was selected 
for study, and while it may be possible that a lower concentration of the DMPC could 
successfully be used, this was not examined in the present study.  
The aggregation state of 5 µmol L-1 ZnPc encapsulated in mixed unsaturated/saturated 
DOPC:DMPC liposomes was determined by examining the UV-vis. absorbance of the 
liposomal suspension over a period of 24 h (Figure 4) for any changes indicative of the 
aggregation of ZnPc – however, none were seen. By measuring the UV-vis. absorption 
spectra of DOPC:DMPC (60:40 wt%) liposomes containing a range of ZnPc concentrations 
(i.e. 1-25 µmol L-1), it was possible to establish the maximum concentration of ZnPc that could 
be incorporated into the liposomal membrane in the monomeric state, using the Beer 
Lambert’s law [42]. These measurements were performed on freshly prepared liposomal 
preparations. The UV-vis. spectra obtained for DOPC:DMPC liposomes containing different 
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amounts of ZnPc are shown in Figure S1 (Supplementary Material), with the insert showing 
the variation in peak intensity at 672 nm as a function of the concentration of entrapped ZnPc. 
These results indicated that as much as 5.00 ± 0.05 mg ZnPc/g lipid could be incorporated 
before aggregation was detected. Figure 4 confirms this result and shows that liposomes 
prepared from a 60:40 wt% DOPC:DMPC could incorporate 5.00 mg ZnPc/g without any 
aggregation being detected. Furthermore, no aggregation of ZnPc was observed in these 
liposomes at 48 h after preparation.  
 
INSERT FIGURE 4 
 
When DOPC liposomes were prepared, the solubility of the monomeric form of ZnPc 
was established to be only 2.00 ± 0.09 mg ZnPc/g DOPC - a result that agrees with data 
previously published by Zimcik and co-workers [44]. The higher solubility of monomeric ZnPc 
in the DOPC:DMPC liposomes c.f. to its solubility in the DOPC liposomes is a consequence 
of the higher solubility of monomeric ZnPc in saturated phospholipids. It is worth noting that 
the UV-vis. spectra revealed no change in the peaks attributable to RuNO over time in either 
the DOPC or the DOPC:DMPC liposomes, suggesting the attainment of an equilibrium 
solubility of ZnPc in the liposomes.  
A light scattering study was performed to investigate how much Tween 20 could be 
incorporated into the liposomes prepared from a 60:40 wt% ratio of DOPC:DMPC at a total 
lipid concentration of 2 mg/mL. These studies are based in the addition of different amounts 
of Tween 20 (range from 0.9 to 25 mmol L-1) to the ethanolic lipid solution used to prepare the 
liposomes and, using light scattering to establish the Tween 20 concentration at which the 
formation of aggregates other than liposomes was observed in the liposome suspension. 
Figure 5(A) shows the variation in the % of each species of aggregate present in a Tween 
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20/lipid mixture containing 2 mg/mL of a 60:40 wt% DOPC:DPMC as a function of Tween 20 
concentration as determined by CONTIN analysis of the light scattering data. Figure 5(B) 
gives the apparent mean hydrodynamic radius of the aggregates after filtration though a 200 
nm pore size filter as a function of Tween 20 concentration.  
 
INSERT FIGURE 5A 
 
INSERT FIGURE 5B 
Significantly, as is clear from Figure 5(A), it was possible to add Tween 20 to the 
DOPC:DMPC at concentrations of up to 5 mmol L-1, and still observe only one species of 
aggregate using dynamic light scattering. As can be seen from Figure 5(B), the addition of 15 
mmol L-1 Tween 20 to the DOPC/DMPC liposomes resulted in an increase in apparent 
hydrodynamic radius from 26.7  1.5 to 52.7  2.5 nm. The increase in apparent liposome 
size upon the addition of Tween 20 is in line with the observations of Morandat and Kirat [47] 
who have suggested that the increase in apparent size is due to the partitioning of the 
surfactant into the liposomal bilayer [47]. At Tween 20 concentrations of 15 mmol L-1 or less 
there was no angular dependence observed in the apparent hydrodynamic size or total 
scattering of the liposomes suggesting that there was no large change in the shape of the 
liposomes under these conditions, supporting the assumption that the liposomes were likely 
to be spherical in shape (Figure S2 Supplementary Material). This result demonstrates that 
below to 15 mmol L-1 of Tween 20, i.e. 250 times the critical micelle concentration (CMC) of 
Tween 20 in water at 0.059 mmol L-1 [48], can be accommodated within the bilayer of the 
DOPC:DMPC liposomes before the need for the formation of other aggregates in solution.  
At Tween 20 concentrations of 25 mmol L-1, two species of aggregates were observed 
using light scattering – one species of an approximate apparent hydrodynamic radius of 6.7 
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nm (Figure 5A), assumed to be Tween 20 micelles, possibly containing a small amount of 
phospholipid, and a second very large, polydisperse species of a mean apparent 
hydrodynamic radius of 161 nm (Figure 5A). Very large, polydisperse aggregates were also 
observed by Lim and Lawrence when determining the effect of the addition of various Tweens 
(i.e. Tween 20, 40, 60, and 80) to phospholipid vesicles [28]. These large aggregates seen at 
added Tween 20 concentrations of 25 mmol L-1 were found to exhibit an angular dependence 
in both their apparent hydrodynamic radius and their total scattering, with the largest apparent 
hydrodynamic radius and highest total scattering being observed at the lowest scattering 
angles (data not shown).  
A corresponding study was performed on liposomes prepared using DOPC to evaluate 
the influence of Tween 20 on the DOPC solubilization. Interestingly, as can be seen in Figure 
6(A), the DOPC liposomes were found to be slightly less resistant to solubilization by Tween 
20, since two species of aggregates could be observed at added Tween 20 concentrations of 
15 mmol L-1 as opposed to 25 mmol L-1 when the liposomes were prepared from a 60:40 wt% 
DOPC:DMPC. Furthermore, the mean apparent hydrodynamic radius of the DOPC liposomes 
in the presence of an added Tween 20 concentration of 15 mmol L-1 was ~ 127 nm as 
opposed to 52.7 nm when prepared using a 60:40 wt% DOPC:DMPC.  
These results suggest that a 9:1 wt% ratio of Tween 20:DOPC (final phospholipid 
concentration of 2 mg/mL) is required to, at least partially, destroy the liposomes. While in the 
60:40 wt% DOPC:DMPC formulation this relation is bigger (15:1 wt% ratio of Tween 
20:DOPC). Morondat and Kirat [47], made a similar observation that liposomes prepared from 
phospholipid mixtures were less resistant to solubilisation by surfactant than those made 
using a single lipid species. 
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INSERT FIGURE 6 
 
As a result of establishing how much Tween 20 can be incorporated into the liposomes 
prepared using 2 mg/mL of DOPC:DMPC liposomes at a weight ratio of 60:40 wt%, it was 
decided to prepare DOPC:DMPC UDLs containing 5 mmol L-1 Tween 20 for the delivery of 
ZnPc and RuNO. The corresponding DOPC/DMPC liposomes prepared in the absence of 
Tween 20 (denoted conventional liposomes, c-Ls) were used as controls. All following studies 
were performed using liposomes of these two compositions.  
 
3.2. Physico-chemical characterization of liposomal preparations 
The apparent hydrodynamic radius of empty and metal-loaded c-Ls and UDLs, 
determined using dynamic light scattering, is shown in Table 1. In agreement with our earlier 
study, the mean apparent hydrodynamic size of the UDLs is approximately twice that of the c-
L, undoubtedly a consequence of the presence of the surfactant, Tween 20, swelling the 
liposomal bilayer. It can be seen that the apparent hydrodynamic size of neither of the c-Ls 
and UDLs changed in the presence of ZnPc and/or RuNO.  
 
INSERT TABLE 1 
 
Regardless of their composition, and the presence or otherwise of one or more of the 
metal compounds, all UDL formulations were very stable with their apparent hydrodynamic 
size when stored at 4 oC for a month in the dark (Table S1 in Supplementary Material). This 
result is in contrast to the apparent hydrodynamic size instability of DMPC liposomes, which 
have been reported to double in apparent hydrodynamic size within 24 h of their preparation 
[28]. The high stability of the liposomes in the present study is undoubtedly a consequence of 
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the presence of DOPC which is known to form stable liposomal apparent hydrodynamic 
preparations.  
The zeta potential of all UDLs formulations in Table 1 were in the range 1.4 (for empty 
UDLs) to −5.5 mV for UDLs containing RuNO. These negatively charged liposomal 
formulations indicating electrostatic stabilization between the liposomes under the present 
experimental conditions, in which showed physical stability during 1 month. Polydispersity 
index (PDI) of all UDLs formulations was less than 0.4 indicating a narrow size distribution of 
these liposomes [49]. DOPC and DMPC are zwitterionic phospholipids, where in the study 
conditions (pH 7.4) the vesicles had an overall negative charge [50].  
 
3.3. Liposome deformability 
Deformability index (DI) results of the UDLs formulations were compared with the 
deformability of the c-Ls preparations, and the results are shown in Table 1. Regardless of the 
presence or absence of a metal compound within the liposomal preparation, all the UDLs 
formulations more rapidly crossed a 100 nm pore filter than any of the c-Ls formulations, for 
example 0.97 mL of a 1 mL empty UDLs suspension crossed the filter in 20 sec as opposed 
0.3 mL of a c-Ls suspension which crossed in 5 min. In addition, the UDLs preparations 
crossing the 50 nm pore size membrane filter very readily, differently to c-Ls formulations. 
Multi-angle dynamic light scattering showed that UDLs preparation there was no change in 
either the apparent hydrodynamic radius and/or shape of the liposomes subsequent to their 
crossing of either the 100 or 50 nm pore size polycarbonate filters. Differently the c-Ls passed 
the 100 nm filter, albeit very slowly, they did not cross the 50 nm pore size filter - most likely 
because the pressure applied to the liposome suspension was insufficient to deform the 
liposomes to force their passage through the filters. 
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Interestingly, neither the presence of one or both of the metal compounds nor the pore 
size of the filter employed altered the DI determined for the UDLs suspensions. Table 1 
shows that the DI value obtained for c-Ls upon passing through a 100 nm pore size filter was 
approximately 6 times lower than the DI measured for the UDLs. Oh and co-workers [21], 
reported that UDLs prepared from a mixture of egg yolk lecithin and cholesterol in the 
presence of Tween 20 possessed a DI 8.5 times that of the c-Ls (i.e. the corresponding c-Ls 
in the absence of Tween 20). The same group of co-workers reported that the nature of the 
edge activator significantly affected the DI value, with UDLs containing Tween 20 exhibiting 
the highest DI. The DI values obtained for the UDLs in the present study are higher than that 
reported by Silva and co-workers [24] for UDLs intended for chloroaluminium phthalocyanine 
delivery and prepared using soybean phosphatidylcholine and containing Tween 80, Span 80 
or sodium deoxycholate. The reason for these differences results is dependent of the method 
of UDLs preparation. The UDLs produced in the present paper were made using the ethanolic 
injection method whereas Silva and co-workers [24] used to thin film hydration method. 
Ascenco and co-workers [23] determined that the presence of ethanol and surfactant acts 
synergically on the flexibility of the lipid bilayer membrane and thus on the liposome’s 
deformability.  
The high value obtained for the UDLs in the present study indicate that they should be 
rapidly able to penetrate the skin [23,51], carrying their payload into the skin. In contrast the 
low DI values achieved for the c-Ls suggest that these preparations are unlikely to pass into 
the skin to any significant extent. 
 
3.4. Degree of retention of entrapped material after liposome extrusion 
The degree of retention (RD), expressed as percentage, of the metal compounds after 
the liposomes passage under pressure through the nanoporous polycarbonate filters at 
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ambient temperature (22 oC) was determined. When UDLs were passed through a 100 nm 
pore size filter, the filtrate was found to contain 97.3  1.3 % RuNO and 98.5  2.3 % ZnPc, 
while after passage through a 50 nm pore size filter, slightly smaller amounts of the metal 
compounds were detected in the filtrate, namely 93.6  1.5 % RuNO and 90.5  2.8 % ZnPc. 
 
3.5. Skin permeation studies 
In order to determine whether UDLs containing ZnPc could enhance the transdermal 
delivery of encapsulated ZnPc, permeation studies were performed using full thickness fresh 
pig ears skin. Note that it has been previously reported that when ZnPc is trapped into c-Ls it 
does not cross the skin in detectable amounts after 24 h [22]. Indeed it is well established that 
c-Ls are of little value as carriers for transdermal delivery of therapeutic molecules. Figure 
7(A) shows the release profile of ZnPc permeated across the fresh pig ear skin over 7 h in the 
present study while Figure 7(B) shows the amount of ZnPc retained in the stratum corneum 
(SC) and the epidermis and dermis at 12 h, i.e. the end of the skin permeation experiments. 
 
INSERT FIGURE 7A 
 
INSERT FIGURE 7B 
 
About 400 µL of a 5 µmol L-1 ZnPc UDLs formulation was applied in the donor 
compartment (1.77 cm2) in the Franz cell under non-occlusive conditions. After 7 h, a total of 
540 ng/cm2 of the applied dose of ZnPc had crossed the pig’s ear skin and was detected in 
the receptor phase of the Franz cells. While after 12 h of application, only 60 ng/cm2 of the 
applied ZnPc dose was retained within the pig skin. The high level of ZnPc determined in the 
receptor phase of the Franz cells suggests that ZnPc is being very efficiently transported into 
the skin by the UDLs, thus indicating that the UDLs were sufficiently deformable to cross the 
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skin and should therefore effectively deliver any entrapped payload into the skin, particularly 
when that payload is a highly hydrophobic drug molecule. 
 
 
3.6. Cell viability 
The effect of UDLs containing ZnPc and/or RuNO, when stored either in the dark or 
under visible irradiation, on the viability of B16-F10 cells was analyzed by means of the MTT 
assay. In the absence of irradiation, the viability of the B16-F10 cell line was unaffected by the 
presence of empty UDLs (Figure 9), showing that the relatively high concentration of Tween 
20 used in the preparation of the UDLs does not affect the viability of the B16-F10 cells. In 
contrast the maximum concentration of free Tween 20 that can be added to the B16-F10 cells 
without toxicity being observed is 0.3 mmol L-1 (Figure S3 in Supplementary Material). 
Significantly, the viability of the B16-F10 cells were not affected by UDLs containing 5 µmol L-
1 RuNO, however, a reduced cell viabilities were observed when UDLs containing ZnPc (0.5 
µmol L-1) (28%) and ZnPc/RuNO (0.5 µmol L-1 + 5 µmol L-1) (36.5%) were evaluted (Figure 8). 
This observation suggests that ZnPc exhibits some toxicity towards the B16-F10 cells even in 
the absence of light activation.  
 
INSERT FIGURE 8 
 
When the cell viability experiments were repeated under irradiation at 675 nm, it can 
be seen (Figure 9) that while the empty UDLs had no effect on cell viability, cell viability 
decreased to approximately 10% that of the control in the presence of UDLs containing ZnPc, 
both in the presence and absence of RuNO. Interestingly the results obtained in this study 
show that the UDLs containing ZnPc and UDLs containing both ZnPc and RuNO decrease 
cell viability to 10 times a lower concentration than when the same compounds are 
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incorporated in stealth liposomes [8]. UDLs system revealed more behaved that conventional 
liposome, with accentuated skin permeation profile and decreasing of 90 % in the cellular 
viability under light irradiation. These results point as excellent candidate in PDT. 
 
INSERT FIGURE 9 
 
3.7. Conclusion 
Dynamic light scattering results indicated that the surfactant Tween 20 might be a 
highly effective edge activator for the preparation of UDLs. Moreover, the substantial skin 
permeation of the photossensitizer, ZnPc when encapsulated in UDLs, observed after topical 
application suggested that UDLs prepared using Tween 20 could be of use in the transdermal 
delivery of either hydrophobic or hydrophilic photosensitizers. Additionally, the reduction in the 
viability of neoplastic cells upon treatment using UDLs containing ZnPc and RuNO occurred 
at a lower concentration than when encapsulated in stealth liposomes.  
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List of Legend 
Figure 1: Structure of the photosensitizer ZnPc (ciane: carbon, blue: nitrogen, white: hydrogen 
and grey: zinc) (A) and the nitrosyl ruthenium complex [Ru(NH.NHq)(tpy)NO]3+ (ciane: 
carbon, blue:nitrogen, red: oxygen, white: hydrogen and purple: ruthenium) (B). 
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Figure 2: Structure of the polyoxyethylene sorbitan monoester (Tween 20). 
 
Figure 3: UV-visible absorption spectra of 5µmol L-1 ZnPc in a solution of DMSO:DMF (solid 
line); ZnPc (5 µmol L-1) + RuNO (50 µmol L-1) loaded in DOPC liposomes (2 mg/mL) over a 
wavelength range 270 – 800 nm at 25.0 ± 2.0 oC. The dashed line represents the data 
obtained from a freshly prepared liposome sample, while the dotted line is the data of the 
same 48 h after preparation. Inset: Magnification over a wavelength range 500 – 800 nm at 
25.0  2.0 oC.  
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Figure 4: UV-visible absorption spectra of 5 µmol L-1 ZnPc in a 1:1 vol% DMSO:DMF solution 
(solid line); 5 µmol L-1 ZnPc + 50 µmol L-1 RuNO loaded in 60:40 wt% DOPC:DMPC vesicles 
over the wavelength range 270 – 800 nm at 25.0  2.0 oC, immediately after preparation 
(dashed line) and 48 h after preparation (dotted line). Inset: magnification of the data over the 
wavelength range 500 – 800 nm. 
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Figure 5: (A) The percent population of aggregate species present in a lipid mixture 
containing 2 mg/mL of a 60:40 wt% DOPC:DPMC as a function of added Tween 20 
concentration (expressed as mmol L-1) as determined by CONTIN analysis of the light 
scattering data) and (B) the apparent mean hydrodynamic radius of the aggregates after 
filtration though a 200 nm pore size filter as a function of Tween 20 concentration (expressed 
as mmol L-1). 
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Figure 6: The percent population of aggregate species present in a lipid solution containing 2 
mg/mL of DOPC as a function of added Tween 20 concentration (expressed as mmol L-1) as 
determined by CONTIN analysis of the light scattering data). 
 
Figure 7: (A) Permeation of ZnPc over time across dermatomed ear pig skin mounted in 
Franz diffusion cells and (B) in vitro profile of ZnPc accumulation in skin layers 12 h after 
topical application. Statistical parameters: n = 6, p < 0.05. 
 
 
 
 
 
 
Figure 8: Cellular viability of B16-F10 cells when stored in the dark. 1 = control; 2 = empty 
UDLs; 3 = UDLs-ZnPc (0.5 µmol L-1); 4 = UDLs-[Ru(NH.NHq)(tpy)NO]3+ (5 µmol L-1); 5 = 
 40 
UDLs-ZnPc/ [Ru(NH.NHq)(tpy)NO]3+ (0.5 µmol L-1 ⁄ 5 µmol L-1). Statistical parameters: n = 3, * 
p > 0.05 and ** p < 0.05. 
 
Figure 9: In vitro phototoxicity against B16-F10 cells. 1 = control; 2 = UDL-ZnPc (0.5 µmol L-
1); 3 = UDL-ZnPc⁄ [Ru(NH.NHq)(tpy)NO]3+ (0.5 µmol L-1/5 µmol L-1). Statistical parameters: n 
= 3, *** p > 0.001. 
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List of Table 
Table 1: Hydrodynamic radius (nm), deformability index (DI) and zeta potential (mV) for 
empty and metal-loaded c-Ls and UDLs after passage through polycarbonate membrane filter 
of either 100 or 50 nm. 
UDLs – 
DOPC:DMPC  
Apparent 
hydrodynamic 
radius (nm)/zeta 
potential (mV)  
Deformability 
index  
(100 nm filter) 
Deformability 
index  
(50 nm filter) 
empty 51.2  4.9 (n = 2)/ 
1.44  0.30 (n=2) 
3.2  0.2 (n = 2) 3.1  0.2 (n = 2) 
RuNO 48.3  5.6 (n = 2)/ 
 -5.50  0.50 (n=2) 
2.9  0.4 (n = 2) 2.3  0.2 (n = 2) 
ZnPc 56.0  7.6 (n = 2)/ 
-2.37  0.52 (n=2) 
3.6  0.5 (n = 2) 3.5  0.7 (n = 2) 
ZnPc/RuNO 49.3  8.2 (n = 2)/ 
-4.74  0.35 (n=2) 
3.2  0.1 (n = 2) 3.6  0.2 (n = 2) 
c-L - 
DOPC:DMPC 
Apparent 
hydrodynamic 
radius (nm)  
Deformability 
index  
(100 nm filter) 
Deformability 
index  
(50 nm filter) 
empty 22.7  1.4 (n = 3) 0.55  0.11 (n = 2) - 
RuNO 23.0  1.4 (n = 3) 0.54  0.07 (n = 2) - 
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ZnPc 21.7  2.1 (n = 3) 0.47  0.03 (n = 2) - 
ZnPc/RuNO 21.9  1.9 (n = 3) 0.42  0.08 (n = 2) - 
 
 
 
 
